TABLE OF CONTENTS
Volume 28, Issue 3 (March 2003)
Preclinicals
Control of 5-Hydroxytryptamine Release in the Dorsal Raphe Nucleus by the Noradrenergic System in Rat Brain. Role of
-Adrenoceptors FREE
A Bortolozzi and F Artigas
Neuropsychopharmacology 28: 421-434; advance online publication, July 19, 2002; doi:10.1038/sj.npp.1300061
Stimulation of P2Y1 Receptors Causes Anxiolytic-like Effects in the Rat Elevated Plus-maze: Implications for the Involvement of P2Y1 Receptor-Mediated Nitric Oxide Production FREE
Holger Kittner, Heike Franke, Wolfgang Fischer, Nina Schultheis, Ute Krügel and Peter Illes
Neuropsychopharmacology 28: 435-444; advance online publication, July 25, 2002; doi:10.1038/sj.npp.1300043
Modulation of Serotonergic Function in Rat Brain by VN2222, a Serotonin Reuptake Inhibitor and 5-HT1A Receptor Agonist FREE
Luz Romero, Pau Celada, Raúl Martín-Ruiz, Llorenç Díaz-Mataix, Marisabel Mourelle, Joaquim Delgadillo, Ildefonso Hervás and Francesc Artigas
Neuropsychopharmacology 28: 445-456; advance online publication, August 9, 2002; doi:10.1038/sj.npp.1300062
Morphine Tolerance and Reward but not Expression of Morphine Dependence are Inhibited by the Selective Glutamate Carboxypeptidase II (GCP II, NAALADase) Inhibitor, 2-PMPA FREE
Piotr Popik, Ewa Kozela, Malgorzata Wróbel, Krystyna M Wozniak and Barbara S Slusher
Neuropsychopharmacology 28: 457-467; advance online publication, August 9, 2002; doi:10.1038/sj.npp.1300048
Expression of Amphetamine-Induced Behavioral Sensitization after Short- and Long-Term Withdrawal Periods: Participation of
- and
-Opioid Receptors FREE
Karin Magendzo and Gonzalo Bustos
Neuropsychopharmacology 28: 468-477; advance online publication, September 13, 2002; doi:10.1038/sj.npp.1300063
Effects of Cocaine on c-Fos and NGFI-B mRNA Expression in Transgenic Mice Underexpressing Glucocorticoid Receptors FREE
M St-Hilaire, P-O Tremblay, D Lévesque, N Barden and C Rouillard
Neuropsychopharmacology 28: 478-489; advance online publication, September 19, 2002; doi:10.1038/sj.npp.1300067
Prefrontocortical Dopamine Loss in Rats Delays Long-Term Extinction of Contextual Conditioned Fear, and Reduces Social Interaction Without Affecting Short-Term Social Interaction Memory FREE
Emilio Fernandez Espejo
Neuropsychopharmacology 28: 490-498; advance online publication, September 20, 2002; doi:10.1038/sj.npp.1300066
Disruption and Potentiation of Latent Inhibition by Risperidone: The Latent Inhibition Model of Atypical Antipsychotic Action FREE
Ina Weiner, Daniela Schiller and Inna Gaisler-Salomon
Neuropsychopharmacology 28: 499-509; advance online publication, September 23, 2002; doi:10.1038/sj.npp.1300069
The GABAB Receptor Agonist Baclofen Attenuates Cocaine- and Heroin-Seeking Behavior by Rats FREE
Patricia Di Ciano and Barry J Everitt
Neuropsychopharmacology 28: 510-518; advance online publication, October 14, 2002; doi:10.1038/sj.npp.1300088
Clinicals
H1-Histamine Receptor Affinity Predicts Short-Term Weight Gain for Typical and Atypical Antipsychotic Drugs FREE
Wesley K Kroeze, Sandra J Hufeisen, Beth A Popadak, Sean M Renock, SeAnna Steinberg, Paul Ernsberger, Karu Jayathilake, Herbert Y Meltzer and Bryan L Roth
Neuropsychopharmacology 28: 519-526; doi:10.1038/sj.npp.1300027
Treatment of Weight Gain with Fluoxetine in Olanzapine-Treated Schizophrenic Outpatients FREE
Juan R Bustillo, John Lauriello, Katherine Parker, Roger Hammond, Laura Rowland, Michael Bogenschutz and Samuel Keith
Neuropsychopharmacology 28: 527-529; advance online publication, October 14, 2002; doi:10.1038/sj.npp.1300089
Allelic Variants of the Functional Promoter Polymorphism of the Human Serotonin Transporter Gene is Associated with Auditory Cortical Stimulus Processing FREE
Jürgen Gallinat, Daniel Senkowski, Catrin Wernicke, Georg Juckel, Isabell Becker, Thomas Sander, Michael Smolka, Ulrich Hegerl, Hans Rommelspacher, Georg Winterer and Werner M Herrmann
Neuropsychopharmacology 28: 530-532; advance online publication, July 25, 2002; doi:10.1038/sj.npp.1300042
Serotonin-Related Gene Polymorphisms and Central Nervous System Serotonin Function FREE
Redford B Williams, Douglas A Marchuk, Kishore M Gadde, John C Barefoot, Katherine Grichnik, Michael J Helms, Cynthia M Kuhn, James G Lewis, Saul M Schanberg, Mark Stafford-Smith, Edward C Suarez, Greg L Clary, Ingrid K Svenson and Ilene C Siegler
Neuropsychopharmacology 28: 533-541; advance online publication, August 29, 2002; doi:10.1038/sj.npp.1300054
Safety, Pharmacokinetics, and Effects on Cognitive Function of Multiple Doses of GTS-21 in Healthy, Male Volunteers FREE
Harumi Kitagawa, Toshiharu Takenouchi, Ryotaro Azuma, Keith A Wesnes, William G Kramer, Donald E Clody and Angela L Burnett
Neuropsychopharmacology 28: 542-551; advance online publication, July 11, 2002; doi:10.1038/sj.npp.1300028
Frequency of Positive Studies Among Fixed and Flexible Dose Antidepressant Clinical Trials: An Analysis of the Food and Drug Administraton Summary Basis of Approval Reports FREE
Arif Khan, Shirin R Khan, Gary Walens, Russell Kolts and Earl L Giller
Neuropsychopharmacology 28: 552-557; advance online publication, September 16, 2002; doi:10.1038/sj.npp.1300059
Healthy Sleepers are Rare: Problems and Success Rates in Establishing a Control Group for Sleep Studies FREE
Ingo Fietze and Konstanze Diefenbach
Neuropsychopharmacology 28: 558-561; advance online publication, October 8, 2002; doi:10.1038/sj.npp.1300082
Methadone Treatment Induces Attenuation of Cerebrovascular Deficits Associated with the Prolonged Abuse of Cocaine and Heroin FREE
Ronald I Herning, Warren E Better, Kimberly Tate, Annie Umbricht, Kenzie L Preston and Jean L Cadet
Neuropsychopharmacology 28: 562-568; advance online publication, September 25, 2002; doi:10.1038/sj.npp.1300073
Cerebrospinal Fluid Corticotropin-Releasing Factor (CRF) and Vasopressin Concentrations Predict Pituitary Response in the CRF Stimulation Test: A Multiple Regression Analysis FREE
D Jeffrey Newport, Christine Heim, Michael J Owens, James C Ritchie, Clayton H Ramsey, Robert Bonsall, Andrew H Miller and Charles B Nemeroff
Neuropsychopharmacology 28: 569-576; advance online publication, September 24, 2002; doi:10.1038/sj.npp.1300071
Influence of Sleep Deprivation on Neuroactive Steroids in Major Depression FREE
Cornelius Schüle, Flavia di Michele, Thomas Baghai, Elena Romeo, Giorgio Bernardi, Peter Zwanzger, Frank Padberg, Augusto Pasini and Rainer Rupprecht
Neuropsychopharmacology 28: 577-581; advance online publication, October 10, 2002; doi:10.1038/sj.npp.1300084
Differentiation between Autism and Multiple Complex Developmental Disorder in Response to Psychosocial Stress FREE
Lucres MC Jansen, Christine C Gispen-de Wied, Rutger-Jan van der Gaag and Herman van Engeland
Neuropsychopharmacology 28: 582-590; advance online publication, August 6, 2002; doi:10.1038/sj.npp.1300046
Lower Cortisol Levels in Depressed Patients with Comorbid Post-Traumatic Stress Disorder FREE
M A Oquendo, G Echavarria, H C Galfalvy, M F Grunebaum, A Burke, A Barrera, T B Cooper, K M Malone and J John Mann
Neuropsychopharmacology 28: 591-598; advance online publication, August 19, 2002; doi:10.1038/sj.npp.1300050
Reduced Pyramidal Cell Somal Volume in Auditory Association Cortex of Subjects with Schizophrenia FREE
Robert A Sweet, Joseph N Pierri, Sungyoung Auh, Allan R Sampson and David A Lewis
Neuropsychopharmacology 28: 599-609; advance online publication, December 3, 2002; doi:10.1038/sj.npp.1300120
Corrigenda
Anxious–Retarded Depression: Relation with Plasma Vasopressin and Cortisol FREE
Remco F P de Winter, Albert M van Hemert, Roel H DeRijk, Koos H Zwinderman, Ank C Frankhuijzen-Sierevogel, Victor M Wiegant and Jaap G Goekoop
Neuropsychopharmacology 28: 610; doi:10.1038/sj.npp.1300154
Plasma Concentrations of Neuroactive Steroids before and after Repetitive Transcranial Magnetic Stimulation in Depression FREE
Frank Padberg, Flavia di Michele, Peter Zwanzger, Elena Romeo, Giorgio Bernardi, Cornelius Schüle, Thomas C Baghai, Robin Ella, Augusto Pasini and Rainer Rupprecht
Neuropsychopharmacology 28: 610-611; doi:10.1038/sj.npp.1300155


